What is it?
What caffeine is
1Caffeine is a methylxanthine stimulant found naturally in coffee, tea, cocoa, guarana and kola, and also sold as isolated caffeine in capsules, tablets, powders, liquids, energy products and pre-workouts. For NootropicsIndex shoppers, the useful comparison is not the serving count alone; it is the milligrams of caffeine per serving, the form, the total caffeine from all sources, and whether the product makes accurate dosing easy.
Names, aliases and forms
Mechanisms of action
Adenosine antagonism explains the alertness signal
7Caffeine's public-facing effect is best understood as temporary alertness support through adenosine-related stimulant activity. That mechanism can support wakefulness and reaction time, but it does not make caffeine a broad memory or learning enhancer, or a compound for disease claims.
Potential effects and evidence map
Human evidence is strongest for acute alertness, wakefulness, vigilance, reaction time and exercise performance. Effects on memory and learning are mixed and often depend on fatigue, baseline use, dose and task type. Safety guidance is mostly about total caffeine intake from all sources and avoiding high-concentration products that make dose control difficult.
Caffeine has strong human evidence for acute wakefulness, reduced sleepiness and vigilance support, especially when baseline alertness is low or fatigue is present.
Caffeine commonly improves reaction time and can support attention or vigilance, but the effect is not the same as broad cognitive enhancement.
Caffeine has strong sports-nutrition evidence for acute exercise-performance support, especially endurance contexts, though response varies and higher doses add side effects.
Memory and learning effects are mixed; caffeine should not be framed as a reliable standalone memory enhancer.
Typical dosages and timing
A review of cognitive and physical performance describes effects across low (~40 mg) to moderate (~300 mg) doses. This study context is not a blanket recommendation, and total caffeine from all sources still matters when comparing a product.
EFSA concludes that habitual caffeine intake from all sources up to 400 mg/day, consumed throughout the day, does not raise safety concerns for general healthy adults. For pregnancy, it uses a lower 200 mg/day all-sources context; it applies that same daily context to lactation. These population-level contexts are not individual targets.
Timing & effect horizon
EFSA's plain-language risk assessment says oral caffeine is rapidly absorbed, with stimulatory effects often beginning 15-30 minutes after ingestion and lasting a number of hours. The average adult The time for blood levels to fall by half during the final elimination phase.Source is about four hours, with a broad 2-8 hour range, so late-day doses can still matter at bedtime.
Safety, side effects and risk profile
Too much caffeine can cause insomnia, jitteriness, anxiety, fast heart rate, nausea and headache.
Caffeine can produce acute stimulant effects relevant to heart rate and blood pressure, and high intakes deserve extra caution in sensitive users.
EFSA reports that human data are insufficient to determine whether caffeine plus p-synephrine changes cardiovascular effects.
With regular caffeine use, tolerance can develop. Abrupt reduction or stopping can produce withdrawal symptoms such as headache, fatigue, decreased alertness and sleepiness.
EFSA uses a 200 mg/day all-sources context in pregnancy and separately applies the same daily context to lactation.
In the U.S., FDA has singled out bulk pure or highly concentrated caffeine powders and liquids for enforcement concern because dose-control errors can be toxic or lethal.
Marketing often overextends caffeine into broad nootropic, fat-loss or productivity claims that are stronger than the alertness and performance evidence supports.
Interactions and cautions
EFSA states that the short- and long-term cardiovascular effects of caffeine plus p-synephrine have not been adequately investigated in humans. That uncertainty does not establish a specific outcome, but it means the combination should not be assumed to have the same safety context as caffeine alone.
Legal and regulatory status
As checked in 2026, FDA guidance on highly concentrated caffeine dietary supplements concerns distinct pure or high-concentration products where a serving must be accurately measured. FDA says certain such products may be adulterated when they present an unreasonable risk of illness or injury. This guidance does not determine the status of every ordinary caffeine food or supplement.
For athletes subject to anti-doping rules, caffeine is on WADA's 2026 Monitoring Program. The program tracks specified substances for use patterns and is distinct from the Prohibited List; it is not an FDA or EFSA determination of food or supplement status.
How it compares
Sports-nutrition reviews often discuss 3-6 mg/kg caffeine protocols and about 60 minutes pre-exercise timing, but those are performance protocols, not general buyer guidance for everyday stimulant use. Consider pre-workouts and endurance products as higher-risk comparison categories because caffeine may be combined with other stimulants.
Practical buying and quality notes
- Capsules, tablets and gummies should make milligrams of caffeine per serving obvious. Powders and liquids should be compared only when the label makes dose math clear, the concentration is not dangerously high for household measuring, and the serving can be measured with appropriate precision. Price per serving is meaningless if the active caffeine amount is hidden inside a proprietary blend.3
- FDA advises consumers to avoid bulk pure or highly concentrated caffeine sold as powder or liquid dietary supplements because accurate measurement is difficult and a small error can be dangerous or lethal. Prefer pre-measured formats, clear Supplement Facts caffeine amounts, lot-specific quality documents and transparent stimulant disclosures.2
FAQ
What caffeine dosage should shoppers compare?
10Start with the stated milligrams of caffeine per serving and total caffeine from all sources. The 40-300 mg/dose study context reflects doses discussed in a cognitive and physical performance review, not a personalized target.
How long does caffeine last?
6EFSA describes oral caffeine effects as starting about 15-30 minutes after ingestion and lasting a number of hours. Adult half-life averages around four hours but ranges roughly 2-8 hours, so late doses can affect sleep even when the obvious stimulation has faded.
Is caffeine a nootropic?
7It is a reliable acute stimulant for wakefulness and reaction-time support in many people, especially when tired. It should not be marketed as a broad memory or learning enhancer, or as a compound for disease claims, because those claims are weaker and more task-dependent.
Are caffeine powders safe to buy?
3Bulk pure or highly concentrated caffeine powders and liquids are a high-risk format because small measurement errors can create toxic doses. FDA specifically advises consumers to avoid these bulk forms. If comparing caffeine products, favor clearly labeled pre-measured servings and avoid proprietary blends that hide the active caffeine amount.
References
- U.S. Food and Drug Administration. Spilling the Beans: How Much Caffeine is Too Much?
- U.S. Food and Drug Administration. Pure and Highly Concentrated Caffeine.
- U.S. Food and Drug Administration. FDA Warns Consumers About Pure and Highly Concentrated Caffeine.
- U.S. Food and Drug Administration. Guidance for Industry: Highly Concentrated Caffeine in Dietary Supplements.
- EFSA NDA Panel. Scientific Opinion on the safety of caffeine. EFSA Journal. 2015;13(5):4102.
- European Food Safety Authority. EFSA explains risk assessment: Caffeine.
- Nehlig A. Is caffeine a cognitive enhancer? Journal of Alzheimer's Disease. 2010;20 Suppl 1:S85-S94.
- Guest NS, VanDusseldorp TA, Nelson MT, et al. International society of sports nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr. 2021;18(1):1.
- World Anti-Doping Agency. The 2026 Monitoring Program.
- McLellan TM, Caldwell JA, Lieberman HR. A review of caffeine's effects on cognitive, physical and occupational performance. Neurosci Biobehav Rev. 2016;71:294-312.
- Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology. 2004;176(1):1-29.
- Klove K, Petersen A. A systematic review and meta-analysis of the acute effect of caffeine on attention. Psychopharmacology. 2025;242(9):1909-1930.